Special Considerations in the Management of HIV-Infected Adolescents

  • Author: Lisa Hightow-Weidman, MD, MPH (More Info)
  • Section Editor: Judith S. Currier, MD, MSc
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 7/5/18 (What's New)

Summary

  • Perinatally and behaviorally infected adolescents face barriers to adherence, such as structural barriers, self-efficacy (one’s sense of their ability to adhere to medications prescribed), and outcome expectancy (one’s sense of benefit from therapy)[Rudy 2008; Rudy 2010]
  • YLHA receiving ART should be routinely screened for adherence levels and offered support services when needed
  • Multimodality interventions are required to address the need for ongoing adherence to ART in adolescents

Action required

Keywords: Adherence, Initial Antiretroviral Therapy, Management of Treatment-Experienced Patients, Pediatric/Adolescent Patients, Pediatric/Adolescent Patients , Treatment Complications

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.